Archive for the ‘Medicaid News’ Category
Stem Cell Transplant Benefits Severe Lupus (CME/CE)
(MedPage Today) -- Allogeneic mesenchymal stem cell transplantation resulted in improvements in disease activity, serologic markers, and renal function in patients with refractory systemic lupus erythematosus (SLE), a pilot study conducted in China found.
Sleep Disorder May Signal Neuro Conditions to Come (CME/CE, with video)
(MedPage Today) -- REM sleep behavior disorder -- in which dreams are accompanied by excessive movement -- may be a sign of neurodegenerative conditions like Parkinson's disease that manifest several decades later, a case series showed.
Test Predicts Kinase Inhibitor Resistance in CML (CME/CE)
(MedPage Today) -- A novel laboratory test may accurately distinguish which chronic myeloid leukemia (CML) patients will develop resistance to imatinib (Gleevec), researchers said.
‘Cell Homing’ Fixes Joints in Rabbit Experiments (CME/CE)
(MedPage Today) -- Researchers are reporting they have successfully persuaded damaged joints to regrow cartilage and bone, using a novel "cell homing" approach.
More Support for Compression-Only CPR (CME/CE, with video)
(MedPage Today) -- CPR with chest compression alone led to outcomes comparable to those achieved with chest compression plus rescue breathing, with a slight edge for compression alone, data from two large clinical trials showed.
Immunotherapy Shows Benefit in Prostate CA (CME/CE)
(MedPage Today) -- A cellular immunotherapy appears to prolong survival among men with metastatic castration-resistant prostate cancer, researchers reported.
Federal Panel Endorses Ticagrelor for ACS
ADELPHI, Md. (MedPage Today) -- An FDA advisory panel has voted overwhelmingly to recommend approval of AstraZeneca's investigational antiplatelet drug ticagrelor (Brilinta), saying it appears more effective than clopidogrel (Plavix) for patients with acute coronary syndrome who will be treated either medically or with PCI.
Eye Vitamin Recalled Over Reports of Choking
(MedPage Today) -- The manufacturers of a softgel supplement marketed as an eye vitamin issued a voluntary recall of the product due to a potential choking hazard.
Soft Endpoint Sought for Pediatric PAH Trial
(MedPage Today) -- An FDA advisory panel will revisit an increasingly familiar battleground this week, as it considers whether a drug sponsor can substitute a surrogate endpoint for a clinical outcome in a pediatric pulmonary arterial hypertension (PAH) trial.
Pharmacy Chain to Pay HHS $1 Million for Privacy Violations
(MedPage Today) -- The East Coast's largest drugstore chain, Rite Aid, settled a Health Insurance Portability and Accountability Act (HIPAA) privacy violation case with the Department of Health and Human Services (HHS) for $1 million.


